Wang F - Search Results

1

Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis.

Bai L, Wang F, Li ZZ, Ren C, Zhang DS, Zhao Q, Lu YX, Wang DS, Ju HQ, Qiu MZ, Wang ZQ, Wang FH, Xu RH. Bai L, et al. Among authors: wang f, wang ds, wang fh, wang zq. Medicine (Baltimore). 2016 Dec;95(51):e4531. doi: 10.1097/MD.0000000000004531. Medicine (Baltimore). 2016. PMID: 28002313 Free PMC article.

2

[Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].

Zhang DS, Jiang WQ, Li S, Zhang XS, Mao H, Chen XQ, Li YH, Zhan J, Wang FH. Zhang DS, et al. Ai Zheng. 2003 Aug;22(8):870-3. Ai Zheng. 2003. PMID: 12917038 Chinese.

3

[Clinical analysis of liver damage of 116 malignant lymphoma patients with chronic HBV infection after cytotoxic chemotherapy].

Li YH, He YF, Wang FH, Lin XB, Xia ZJ, Sun XF, Lin TY, Huang HQ, Zhang L, Xu RH, Jiang WQ, Guan ZZ. Li YH, et al. Ai Zheng. 2005 Dec;24(12):1507-9. Ai Zheng. 2005. PMID: 16351802 Chinese.

4

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Li YH, Wang FH, Jiang WQ, Xiang XJ, Deng YM, Hu GQ, Xu DM, Chen Y, Lin Q, He YJ. Li YH, et al. Cancer Chemother Pharmacol. 2008 Aug;62(3):539-44. doi: 10.1007/s00280-007-0641-2. Epub 2008 Jan 3. Cancer Chemother Pharmacol. 2008. PMID: 18172651 Clinical Trial.

5

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.

He YF, Li YH, Wang FH, Jiang WQ, Xu RH, Sun XF, Xia ZJ, Huang HQ, Lin TY, Zhang L, Bao SP, He YJ, Guan ZZ. He YF, et al. Ann Hematol. 2008 Jun;87(6):481-5. doi: 10.1007/s00277-008-0454-3. Epub 2008 Feb 26. Ann Hematol. 2008. PMID: 18299831

6

Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy.

An X, Li YH, Lin XB, Wang FH, Feng F, Xu RH, Jiang WQ, He YJ. An X, et al. Among authors: wang fh. Ai Zheng. 2009 Mar;28(3):286-91. Ai Zheng. 2009. PMID: 19619444 Free article.

7

[Efficacy of FORFIRI regimen on oxaliplatin-based chemotherapy-failed advanced colorectal cancer].

Li YH, Wang FH, Zhang DS, Wang ZQ, Feng F, Zhang L, Xu RH, Jiang WQ, He YJ. Li YH, et al. Among authors: wang fh, wang zq. Ai Zheng. 2009 Sep;28(9):913-8. doi: 10.5732/cjc.008.10571. Ai Zheng. 2009. PMID: 19728906 Free article. Clinical Trial. Chinese.

8

[Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].

Li YH, An X, Xiang XJ, Wang ZQ, Wang FH, Feng F, Jiang WQ, He YJ, Xu RH. Li YH, et al. Among authors: wang fh, wang zq. Ai Zheng. 2009 Sep;28(9):939-44. doi: 10.5732/cjc.009.10001. Ai Zheng. 2009. PMID: 19728911 Free article. Chinese.

9

[Efficacy and prognostic analysis on surgical resection of pulmonary metastasis from colorectal cancer].

Feng F, Li YH, An X, Wang FH, Xu RH, Pan ZZ, He YJ, Wan DS. Feng F, et al. Among authors: wang fh. Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Sep;12(5):471-3. Zhonghua Wei Chang Wai Ke Za Zhi. 2009. PMID: 19742336 Chinese.

10

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.

Li YH, Luo HY, Wang FH, Wang ZQ, Qiu MZ, Shi YX, Xiang XJ, Chen XQ, He YJ, Xu RH. Li YH, et al. J Cancer Res Clin Oncol. 2010 Apr;136(4):503-10. doi: 10.1007/s00432-009-0682-5. Epub 2009 Sep 24. J Cancer Res Clin Oncol. 2010. PMID: 19777259 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,838 results

Search Page

Filters